MD PhdUniversity of IOWAIowa city, Iowa, United States
OC 43.5 - Should immune tolerance be pursued in the era of Emicizumab? Longitudinal follow up of a FVIII inhibitor cohort - Real World Data
Monday, June 26, 202315:45 – 16:00 ET
OC 49.1 - 3K3A-Activated Protein C treatment exerts anti-inflammatory and blood barrier stabilizing effects in the retina, and inhibits choroidal neovascularization
Monday, June 26, 202314:45 – 15:00 ET
PB0627 - Management of invasive procedures in patients with Hemophilia A receiving Emicizumab prophylaxis: Real-world data from a national Hemophilia treatment center.
Monday, June 26, 202318:30 – 19:30 ET
